Harnessing the immune system to improve outcomes and save lives.

Recent Developments

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod

Tivic Growth Backed By $90M+ Financing Package